arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MEDIFAST INC

MED
$11.96 ▼ -0.15 (-1.24%) at close
Consumer Staples ·Miscellaneous Food Preparations & Kindred Products ·USMiscellaneous Food Preparations & Kindred Products
68 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

MEDIFAST INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $133.2M
Dividend Yield
Revenue Growth -27.6%
Op. Margin -5.7%
ROIC -2.3%
FCF / Share $0.07
Trailing P/E
Price / Book 0.7x
FCF Yield 0.6%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$76.38M
↓ -27.6%
Net Income Profit after all expenses
$-2.12M
↓ -174.9%
Operating Margin Operating profit as % of sales
-5.7%
↓ -30.7% 22th
FCF / Share Free cash flow per share
$0.07
↑ +186.1%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
23
Returns
35
Cash Quality
20

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters